Irritable Bowel Syndrome Treatment Market Size, Trends and Growth Analysis by 2031

The global irritable bowel syndrome treatment market size was valued at USD 1,444.7 million in 2022. It is estimated to reach USD 4,409.56 million by 2031, growing at a CAGR of 13.2% during the forecast period (2023&ndash;2031). Several pharmaceutica Report Scope:<table><tr><td>Report Metric</td><td>Details</td></tr><tr><td><strong>Study Period</strong></td><td>2019-2031</td></tr><tr><td><strong>Historical Period</strong></td><td>2019-2021</td></tr><tr><td><strong>Forecast Period</strong></td><td>2023-2031</td></tr><tr><td><strong>Base Year</strong></td><td>2022</td></tr><tr><td><strong>Base Year Market Size</strong></td><td>USD 1,444.7 Million</td></tr><tr><td><strong>Forecast Year</strong></td><td>2031</td></tr><tr><td><strong>Forecast Year Market Size</strong></td><td>USD 4409.56 Million</td></tr><tr><td><strong>Forecast Year CAGR</strong></td><td>13.2%</td></tr> <tr><td><strong>Largest Market</strong></td><td>North America</td></tr><tr><td><strong>Fastest Growing Market</strong></td><td>Europe</td></tr> </table>

全球功能性肠病治疗市场规模于2022年达到14.447亿美元。据预测，至2031年，该市场规模将增至44.0956亿美元，在预测期内（2023年至2031年）将以13.2%的复合年增长率增长。本报告涵盖范围包括：

<table>
<tr>
<td>报告指标</td>
<td>详细信息</td>
</tr>
<tr>
<td><strong>研究周期</strong></td>
<td>2019年至2031年</td>
</tr>
<tr>
<td><strong>历史周期</strong></td>
<td>2019年至2021年</td>
</tr>
<tr>
<td><strong>预测周期</strong></td>
<td>2023年至2031年</td>
</tr>
<tr>
<td><strong>基准年份</strong></td>
<td>2022年</td>
</tr>
<tr>
<td><strong>基准年份市场规模</strong></td>
<td>14.447亿美元</td>
</tr>
<tr>
<td><strong>预测年份</strong></td>
<td>2031年</td>
</tr>
<tr>
<td><strong>预测年份市场规模</strong></td>
<td>44.0956亿美元</td>
</tr>
<tr>
<td><strong>预测年份CAGR</strong></td>
<td>13.2%</td>
</tr>
<tr>
<td><strong>最大市场</strong></td>
<td>北美</td>
</tr>
<tr>
<td><strong>增长最快的市场</strong></td>
<td>欧洲</td>
</tr>
</table>